Equities Analysts Set Expectations for Travere Therapeutics,

Travere Therapeutics, Inc. (NASDAQ:TVTX – Get Rating) – Investment analysts at Jefferies Financial Group issued their Q1 2022 earnings estimates for shares of Travere Therapeutics in a research note issued to investors on Monday, April 25th. Jefferies Financial Group analyst M. Raycroft anticipates that the company will earn ($0.63) per share for the quarter. Jefferies […]

Related Keywords

Canada , Texas , United States , Ericm Dube , Piper Sandler , Peter Heerma , Lindbrook Capital , Securities Exchange Commission , Zacks Investment Research , Travere Therapeutics Inc , Nasdaq , Jefferies Financial Group , Nisa Investment Advisors , Advisor Group Holdings Inc , Royal Bank , Travere Therapeutics , Get Rating , Financial Group , Travere Therapeutic , Investment Research , Group Holdings , Investment Advisors , Teacher Retirement System , Exchange Commission , Nasdaq Tvtx , Tvtx , Medical , Earnings Estimates , Jefferies Financial Group Inc ,